MetaCap

TuHURA Biosciences Insider Trades

NASDAQ: HURAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.96+0.03 (+1.55%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
0 · $0
Shares bought / sold
0 / 0
Net activity
Net buying $0

TuHURA Biosciences insider activity

Over the last 12 months, TuHURA Biosciences insiders reported 1 transaction on SEC Form 4: 0 open-market purchases and 0 sales. The most recent filing shows Bianco James A. (Chief Executive Officer) reporting a transaction in 150,000 shares on May 28, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put HURA's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

HURA insider transactions

TuHURA Biosciences insider transactions
DateInsiderTypeSharesValueFiling
May 28, 2026Bianco James A.Chief Executive OfficerGift150,000—Form 4
Oct 18, 2024Bianco James A.Chief Executive OfficerAward2,323,307—Form 4
Jun 1, 2023Hoffman Robert E.President, CEO, and CFOAward59,800—Form 4
Jan 5, 2023Brown Dennis MChief Scientific Officerother363—Form 4
Aug 1, 2022Hoffman Robert E.President and CEOAward400,145—Form 4
Aug 1, 2022Praill Anthony ScottChief Financial OfficerAward240,087—Form 4
Aug 1, 2022Brown Dennis MChief Scientific OfficerAward240,087—Form 4
Feb 15, 2022Hoffman Robert E.President and CEOBuy55,000$25.80KForm 4
Dec 8, 2021Praill Anthony ScottChief Financial OfficerBuy28,700$19.43KForm 4
Dec 7, 2021Zarrabian SaiidHead of Strategic PartnershipsBuy38,109$24.30KForm 4
Dec 6, 2021Zarrabian SaiidHead of Strategic PartnershipsBuy11,891$7.02KForm 4
Nov 22, 2021Johnson Laura L.DirectorBuy3,000$2.23KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related